Journal
INTERNAL MEDICINE
Volume 56, Issue 4, Pages 395-400Publisher
JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.56.7669
Keywords
sinusoidal obstruction syndrome; chemotherapy; cyclophosphamide; jaundice; drug-induced liver injury
Categories
Ask authors/readers for more resources
Hepatic sinusoidal obstruction syndrome (SOS), a serious complication that mainly occurs after hematopoietic-stem cell transplantation (HSCT), is caused by damage to the sinusoidal endothelial cells after the obstruction of the sinusoid. Recently, hepatic SOS was reported to occur after non-HSCT chemotherapies. This report describes a patient who experienced hepatic SOS after non-HSCT chemotherapy for non-Hodgkin lymphoma. A liver biopsy showed the slight dilatation of the hepatic sinusoid, which may be indicative of hepatic SOS. Hepatic SOS should be included in the differential diagnosis of patients with severe liver injury following the administration of chemotherapy regimens that are toxic to the vascular endothelial cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available